Kyoko Ueda
Suita, 5650871, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
BRAF V600E-induced distinct DNA damage response defines the therapeutic potential of p53 activation for TP53 wild-type colorectal cancer.
Journal: Carcinogenesis
Published: October 14, 2023
Bearing 19q13 aberration predicts poor prognosis in non-germinal centre type of CD5+ DLBCL.
Journal: British journal of haematology
Published: October 28, 2017
Efficacy of chemotherapy in extremely elderly patients with diffuse large B-cell lymphoma.
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: June 09, 2017
Epstein-Barr virus-negative extranodal "true" natural killer-cell lymphoma harbouring a KDM6A mutation.
Journal: Hematological oncology
Published: April 18, 2017
Incidence and risk factors of febrile neutropenia in patients with non-Hodgkin B-cell lymphoma receiving R-CHOP in a single center in Japan.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: March 29, 2017
Treatments and Outcomes of Patients With Extranodal Natural Killer/T-Cell Lymphoma Diagnosed Between 2000 and 2013: A Cooperative Study in Japan.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 31, 2016
Myelomatous meningitis: a case report.
Journal: International journal of hematology
Published: April 05, 2016
Frequent BCOR aberrations in extranodal NK/T-Cell lymphoma, nasal type.
Journal: Genes, chromosomes & cancer
Published: October 22, 2015
Rapid progression of anemia related to tumor-lysis syndrome associated with bortezomib treatment in myeloma patients.
Journal: Japanese journal of clinical oncology
Published: March 26, 2014
Last Updated: 09/26/2026